Delivery Order SPE2DR25D2104-SPE2DR26F3SDM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Icosapent Ethyl 1 gram capsules (120 count) with a ceiling value of $2,242.79. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The work is scheduled for completion by August 1, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Icosapent Ethyl 1 Gram Capsules (120-count units) under a firm fixed-price contract with a ceiling value of $1,163.46. The delivery order was awarded competitively on December 1, 2025, with a completion date of December 2, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside designation, reflecting the competitive nature of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count units) with a ceiling value of $1,055.67. This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $3,417.46. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Icosapent Ethyl 1 Gram Capsule 120-count units, with a contract ceiling value of $3,250.80. This non-set-aside award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, utilizing firm fixed pricing under a delivery order contract type. The pharmaceutical product will be performed at AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) valued at $1,163.85. This is a firm fixed-price delivery order with an ultimate completion date of December 11, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Icosapent Ethyl 1 Gram capsules (120-count packaging) with a firm fixed price of $1,261.20 and a completion date of September 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026....
- This delivery order, valued at $2,322.47, was awarded to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with an ultimate completion date of October 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, which serves the Department of Defense's medical supply chain requirements, is the funding federal agency, and the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count bottles) with a ceiling value of $3,471.13. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competitive procurement. The contract is scheduled for ultimate completion on May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule in a quantity of 120 units, with a ceiling value of $1,161.66. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 9, 2025. This delivery order...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SDMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Icosapent Ethyl 1 gram capsules (120-count) valued at $1,161.38, with an ultimate completion date of December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, as a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for the Defense Health Agency and other federal healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's extensive portfolio of federal medical contracts demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/21/25 |